Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR™ in Head and Neck Squamous Cell Carcinoma

[ASFN Admin]

Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaRTM in Head and Neck Squamous Cell Carcinoma RaDaR demonstrated 100% specificity in patients with no recurrence and 100% sensitivity in patients with clinical recurrence Research Triangle Park, NC, USA and Cambridge, UK, 11 February 2022 -- Inivata, a leader in liquid biopsy, today announced clinical validation data for its RaDaRTM liquid biopsy test in head and neck squamous cell carcinoma (HNSCC). The dat

Continue reading...